Skip to main content

Advertisement

Log in

Advanced Hepatocellular Carcinoma in a Patient with Type 1 Neurofibromatosis

  • Case Report
  • Published:
Hellenic Journal of Surgery

Abstract

The rare case is reported of advanced hepatocellular carcinoma (HCC) in a 50-year-old male with type 1 neurofibromatosis (NF 1). The patient presented in the surgical outpatient department with a 4-year history of multiple neurofibromas over the trunk and complaints of pain in the right upper abdomen for 4 months, progressive weight loss and loss of appetite. Investigation for both the abdominal complaints and the multiple neurofibromas led to the diagnosis of advanced HCC (according to the Barcelona Clinic Liver Cancer Sstaging and Treatment Strategy) with NF 1, and the patient is being managed on oral Sorafenib as palliative treatment. NF 1 occurs due to mutation in the NF 1 gene located on 17q, which codes for the protein neurofibromin, which has a tumor suppressor function. NF1 presents rarely with malignancy, in which case tumors of the central nervous system are the most common type. To the best of our knowledge this is only the second documented case of NF 1 presenting with HCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Korf B. Malignancy in neurofibromatosis type 1. The Oncologist 2000;5:477–85.

    Article  PubMed  CAS  Google Scholar 

  2. Lewis RA, Gerson LP, Axelson KA, et al. von Recklinghausen neurofibromatosis. II. Incidence of optic gliomata. Ophthalmology 1984;91:929–35.

    Article  PubMed  CAS  Google Scholar 

  3. Martin GA, Viskochil D, Bollag G, et al. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell 1990;63:843–9.

    Article  PubMed  CAS  Google Scholar 

  4. Ishioka C, Ballester R, Engelstein M, et al. A functional assay for heterozygous mutations in the GTPase activating protein related domain of the neurofibromatosis type 1 gene. Oncogene 1995;10:841–7.

    PubMed  CAS  Google Scholar 

  5. Calvisi DF, Ladu S, Conner EA, et al. Inactivation of Ras GTPase-activating proteins promotes unrestrained activity of wild-type Ras in human liver cancer. J Hepatol 2011;54:311–9.

    Article  PubMed  CAS  Google Scholar 

  6. Walker L, Thompson D, Easton D, et al. A prospective study of neurofibromatosis type 1 cancer incidence in the UK. Br J Cancer 2006;95:233–8.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  7. Sorensen SA, Mulvihill JJ, Nielsen A. Long-term follow-up of von Recklinghausen neurofibromatosis: Survival and malignant neoplasms. N Engl J Med 1986;314:1010–5.

    Article  PubMed  CAS  Google Scholar 

  8. Huson SM, Harper PS, Compston DAS. Von Recklinghausen neurofibromatosis: A clinical and population study in South-East Wales. Brain 1988;111:1355–81.

    Article  PubMed  Google Scholar 

  9. Friedman JM, Birch PH. Type 1 neurofibromatosis: A descriptive analysis of the disorder in 1728 patients. Am J Med Genet 1997;70:138–43.

    Article  PubMed  CAS  Google Scholar 

  10. Kimura T, Tanaka N, Umemura T, et al. Primary hepatocellular carcinoma in a patient with neurofibromatosis type I. Liver International 2015:210–15.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Poras Chaudhary.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chaudhary, P., Munjewar, C. & Kumar, R. Advanced Hepatocellular Carcinoma in a Patient with Type 1 Neurofibromatosis. Hellenic J Surg 90, 151–153 (2018). https://doi.org/10.1007/s13126-018-0461-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13126-018-0461-3

Key words

Navigation